The goal of this clinical trial is to learn whether a group-based HIV prevention program can improve HIV knowledge, prevention behaviors, and testing in older Black women aged 50 and older who live in subsidized housing. The study focuses on improving how HIV prevention programs address the unique needs and life experiences of older Black women.
The main questions it aims to answer are:
Can a revised HIV prevention intervention tailored to reproductive health histories improve HIV knowledge, condom use, and testing in older Black women?
Is the intervention feasible, acceptable, and engaging for participants?
The PI will compare a group of participants receiving the Woman-2-Woman (W2W) intervention to a wait-listed control group to see if the intervention leads to better HIV prevention outcomes.
Participants will:
Join a group-based HIV prevention program designed for older Black women
Be randomly assigned to either:
Start the intervention right away, or
Join a waitlist and start the program 4 weeks later
Take part in four weekly sessions that include group discussions, education, and skill-building activities
Share information about their reproductive health histories and sexual health decisions during focus groups or surveys
Complete questionnaires at the start, after the program ends, and 4 weeks later to assess HIV knowledge, condom use, and testing behavior
This research aims to create a culturally tailored, evidence-based HIV intervention that fits the lives and needs of older Black women and can be used in future, larger studies.
At least 50 years of age
A resident of Selected sites
A MOCA score of less than 24
Self-identifying as an African American woman
Pre-menopausal
Cognitive impairment
Parallel
Adapted W2W
BehavioralHIV education sessions and questionnaires.
Waitlist Control
BehavioralHIV education sessions and questionnaires given 4 weeks after W2W intervention.
Recruitment rate
Feasibility will be measured by recruitment rate (number of participants who sign the informed consent divided by those participants who meet the eligibility criteria)
Acceptability
Acceptability will be measured by program satisfaction evaluations. Participants rate statements (1-5) with higher scores equating to greater satisfaction.
Retention Rate
Feasibility will also be measured by retention rate (number of participants who complete all 4 sessions divided by those participants who signed the informed consent)
Change in HIV Knowledge
HIV knowledge will be measured by the HIV-KQ-18. Scores range from 0-18 with higher scores equating to greater HIV knowledge.
Click on the lead sponsor to view all of their trials.
Laneshia Conner
Lead sponsor
University of Kentucky
Sponsor institution
National Institute on Aging (NIA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
